Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Akeso Awarded as 2021 "Most Honored Company" by Institutional Investor 2021-06-30 16:00
Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States 2021-05-24 18:17
ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer 2020-08-13 20:07
Akeso Appoints Prof. Bradley Monk as Lead Gynecologic Oncology Advisor and Chair of the Steering Committee 2020-06-24 12:55
1 2 3 4 5